This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (15)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Lincoln J. Bynum, MD; Colleen M. Crotty, MS; James E. Wilson III, MD

Arch Intern Med. 1979;139(3):283-285.

Abstract
Blood tests for fibrinogen/fibrin degradation products (FDP/fdp) and soluble fibrin complexes (SFC) were performed in 100 patients at high risk for thromboembolism in order to assess the diagnostic value of these determinations in patients suspected to have pulmonary embolism. Tests were positive significantly less often in high-risk patients, and mean values were significantly lower, when compared with patients with established pulmonary embolism (P <.001). However, no significant differences existed between high-risk patients and patients with deep venous thrombosis of the legs. Positivity rates and mean values were significantly higher in the presence of pulmonary embolism than in patients with deep venous thrombosis alone (P <.05). Elevated FDP/fdp and SFC values are useful in the diagnosis of pulmonary embolism in high-risk patients; moreover, positive results in a patient with deep venous thrombosis suggests that pulmonary embolism has occurred.

(Arch Intern Med 139:283-285, 1979)

Author Affiliations
From the Pauline and Adolph Weinberger Laboratory for Cardiopulmonary Research, University of Texas Health Science Center, Dallas.

Footnotes
Accepted for publication Sept 21, 1978.

Reprint requests to Pulmonary H8 116, 5323 Harry Hines Blvd, Dallas, TX 75235 (Dr Bynum).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diagnosis of Pulmonary Embolism
Fulkerson et al.
Arch Intern Med 1986;146:961-967.
ABSTRACT